Neoleukin Therapeutics, Inc(NASDAQ:NLTX) 
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines inte...
Website: http://www.neoleukin.com
Full Time Employees: 65
CEO: Jonathan G. Drachman
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-22
P
O 35.69
H 35.69
L 33.05
C 33.81
V 29,628
10EMA 33.81
20EMA 33.81
60EMA 33.81
120EMA 33.81
250EMA 33.81